“roger-tung” Archives

in
Entry Author Date Location
With FDA’s Eye on JAK Drugs, Concert Moves One Ahead For Hair Loss 09/03/19 Boston
East Coast Biotech Roundup: Concert, Merrimack, Vertex, & More 05/02/14 Boston
How A Kidney Drug Almost Torpedoed Concert Pharma’s IPO 04/25/14 Boston
Concert Pharma To Get $300M+ Per Drug in Celgene Pact 05/06/13 Boston
Concert Pharma, Jazz Pharma Strike $120M Deal for Narcolepsy 02/26/13 Boston
Concert Nabs $200M Deal From Avanir to Make Psych Drugs 02/29/12 Boston
Verastem, the 15-Month Old Christoph Westphal Venture in Cancer Stem Cells, Seeks IPO 11/03/11 Boston
Concert Pharmaceuticals Hits $4 Million Milestone in GSK Alliance 06/20/11 Boston
Conatus Gets Idun, Trius Goes Public, BrainCells Gets Sabcomeline, & More San Diego-Area Life Sciences News 08/05/10 San Diego
How Eli Lilly Let a Billion-Dollar Molecule Slip Away and Make a Fortune for Vertex 08/04/10 Boston
Adimab Inks Novartis Deal, GSK-Founded Tempero Pursues Hot Immunology Field, Metamark Gets $22M, & More Boston-Area Life Sciences News 07/16/10 Boston
Concert Pharma Riding Potential $1B Glaxo Deal, Looks Ahead to Human Data on HIV Drug 07/14/10 Boston
XSITE’s Biotech Gurus to Cover the State of New England Biotech, the Return of Platforms 06/07/10 Boston
The Vertex Alumni: Where Are They Now? 04/29/10 Boston
Concert Starts HIV Trial, Bags $12M From Glaxo to Help Challenge Gilead’s Once-Daily Pill 11/09/09 Boston
Concert Pharma Jamming with Glaxo in Deal with $1B-Plus Potential 06/02/09 Boston
Biogen Idec Makes Controversial Tysabri Decision, Boston Scientific Explains Stock Sales, Charles River Heads to China, & More Boston-Area Life Sciences News 10/16/08 Boston
Concert Pharmaceuticals, Flush With Well-Timed Venture Round, Aims for Hot Flashes, HIV 10/14/08 Boston
Concert Pharmaceuticals Enters Clinical Trials with Drug for Hot Flashes 09/25/08 Boston
Heavyweight Hydrogen Takes $37 Million Prize for Concert Pharmaceuticals 05/01/08 Boston
Page 1 of 1